// App-Quantinova.ai

S5197 2016 AHA : Left Atrial Dimensions Can Help in Predicting Thromboembolic Risk in Non Valvular Atrial Fibrillation Patients Treated With Direct Oral Anticoagulants

Researchers

Presenter

  • Antonio Fusto

Principal Investigators

  • Riccardo Di Pietro

  • Nicolo Salvi

  • Paola Scarparo

  • Alessandra Cinque

  • Ilaria Mancini

  • Gennaro Alfano

  • Massimo Mancone

  • Fabio Ferrante

  • Francesco Fedele

Medical Centers

  • Sapienza University of Rome, ROMA, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Peripheral arterial embolism

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

  • Non-valvular atrial fibrillation

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved